(جينزبورغ) شرح لماذا الوقت مبكر جداً للحديث عن علاج لقاح السرطان

The first patient completed a course of treatment with a vaccine against melanoma, the scientific director of the N. F. Gamalei Center Alexander Ginzburg told TASS.

He noted that the patient has no metastases, but it is too early to talk about his complete treatment. " إن عدم وجود مثبتات لا يعني علاجا كاملا، والعلاج للسرطان هو ٥ سنوات من الملاحظات، ولم تكن هناك ٥ سنوات، وهي الآن خمسة أشهر قادمة للتو " .

As Ginzburg emphasized, that is why the Ministry of Health will continue to monitor patients who have completed treatment with oncological vaccine.

The first patient received the personalized antitumor mRNA vaccine Neonkovak for the treatment of skin melanoma in April 2026. وقد تم تطوير هذا العقار بالاشتراك مع مركز غاماليا. The vaccine is made individually for each patient, it must adjust the immune system to recognize and destroy tumor cells.